Thomas Nickolas, MD MS
2 clinical trials · Sponsor
◉ Watch Thomas Nickolas, MD MS
| Record | Firm | Date |
|---|---|---|
| The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients (NCT03960554) | Thomas Nickolas, MD MS | 2020-01-16 |
| The Effect of Etelcalcetide on CKD-MBD (NCT03960437) | Thomas Nickolas, MD MS | 2018-09-06 |
Track Thomas Nickolas, MD MS automatically
Every clearance here is in the API, with alerts when new ones post.